跳至主要内容
临床试验/EUCTR2008-002610-21-NL
EUCTR2008-002610-21-NL进行中(未招募)不适用

Mechanisms of albuminuria in diabetes; reversal of injury to the glycocalyx by the ACE inhibitor lisinopril - MADRIGA

Academic Medical Centre0 个研究点开始时间: 2008年5月29日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • Caucasian males
  • Diagnosis of type 1 diabetes
  • Urinary alb/creat ratio < 3.5 mg/mmol, without antiproteinuric treatment
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Hypertension (RR syst > 140 mmHg, RR diast. > 90 mmHg)
  • Previous use of RAS inhibitors
  • Primary dyslipidemia's
  • Use of statins during the six weeks before visit 1
  • Use of antioxidants in the two weeks prior to visit 1
  • Angioedema in medical history
  • Hypersensitivity to ACE inhibitors

研究者

发起方
Academic Medical Centre

相似试验